earnings
TA
NASDAQ · TAK
Takeda Pharmaceutical Company Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$18.03
Down-$0.03 (-0.17%)
Updated Aug 31, 2026, 2:03 PM
SID Score
5.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 45.42B
- P/E ratio
- 50.83
- Dividend yield
- 3.67%
- 52-week range
- $12.99 – $18.90
- Volume
- 1.81M
- Avg. volume
- 2.78M
Price performance
TAK price history
1M range · 20 trading sessions · Daily adjusted prices
TAK closed at $18.03 after 20 trading sessions, up 7.13% for the selected period.
- Last close
- $18.03
- Period change
- +7.13%
- Period low
- $16.56
- Period high
- $18.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $18.00 | $18.11 | $17.96 | $18.03 | 1.81M |
| Aug 27, 2026 | $18.21 | $18.22 | $17.971 | $18.03 | 1.73M |
| Aug 26, 2026 | $18.32 | $18.38 | $18.2191 | $18.23 | 2.33M |
| Aug 25, 2026 | $18.21 | $18.355 | $18.21 | $18.35 | 1.25M |
| Aug 24, 2026 | $18.24 | $18.26 | $18.11 | $18.24 | 2.23M |
| Aug 21, 2026 | $18.09 | $18.245 | $18.08 | $18.18 | 1.48M |
| Aug 20, 2026 | $18.25 | $18.34 | $18.105 | $18.13 | 2.23M |
| Aug 19, 2026 | $18.22 | $18.495 | $18.22 | $18.34 | 3.31M |
| Aug 18, 2026 | $17.86 | $18.16 | $17.8341 | $18.05 | 3.81M |
| Aug 17, 2026 | $17.40 | $17.4398 | $17.28 | $17.38 | 2.47M |
| Aug 14, 2026 | $17.50 | $17.66 | $17.48 | $17.63 | 3.14M |
| Aug 13, 2026 | $17.47 | $17.47 | $17.36 | $17.39 | 1.95M |
| Aug 12, 2026 | $17.36 | $17.47 | $17.35 | $17.41 | 2M |
| Aug 11, 2026 | $17.38 | $17.635 | $17.36 | $17.48 | 2.34M |
| Aug 10, 2026 | $17.48 | $17.61 | $17.42 | $17.55 | 4.17M |
| Aug 7, 2026 | $17.48 | $17.56 | $17.405 | $17.45 | 4.25M |
| Aug 6, 2026 | $17.07 | $17.275 | $16.91 | $17.02 | 4.27M |
| Aug 5, 2026 | $16.66 | $16.78 | $16.57 | $16.72 | 4.87M |
| Aug 4, 2026 | $16.35 | $16.681 | $16.30 | $16.56 | 5.91M |
| Aug 3, 2026 | $17.19 | $17.22 | $16.83 | $16.83 | 3.15M |
Latest TAK news
The latest Smart Investors Daily articles mentioning TAK.
Stock researchResearch & News · News
Loading stock research…